• Other

    Other
  • CN

    CN
  • EU

    EU
  • EN

    EN
    • 我的购物车
    购物车中还没有商品，赶紧选购吧！
    • 产品名称
    • 规格
    • 数量
    • 总价
      已选择商品 : 0 件 总计 : 结账()
      Birinapant (TL32711)
      Birinapant (TL32711)

      售价：
      市场价：

      产品仅用于科学研究，不针对患者销售
      数量： - + 件（库存件）
      InvivoChem目录号 #: V0051
      CAS号码 #： 1260251-31-7纯度 ≥98%

      Description: Birinapant (TL32711; TL-32711; TL 32711) is a novel and potent bivalent peptidomimetic of SMAC (second mitochondrial-derived activator of caspases) and inhibitor of IAP (Inhibitor of Apoptosis Protein) family proteins. It has potential anticancer activity. Birinapant is a SMAC mimetic antagonist, mostly to cIAP1 with a Kd of<1 nM in a cell-free assay, and is less potent to XIAP. 

      References: Breast Cancer Res Treat. 2013 Jan;137(2):359-71.
      Customer Validation
      InvivoChem产品被CNS顶刊文章引用
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, 597(7874):119-125.
      • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, 183(5):1202-1218.e25
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, 597(7874):119-125.
      • Citation of InvivoChem Larotrectinib (V2599) by Cell 2020, doi: 10.1016/j.cell.2020.10.016.
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, doi: 10.1126/sciadv.abm9427.
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem Vitrakvi by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, PMID: 36103522.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, DOI: 10.1038/s41586-021-03850-3.
      • Citation of InvivoChem LOXO-101 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022, PMID: 36103522.
      • Citation of InvivoChem Vorinostat/SAHA (V0255) by Nature 2021, PMID: 34433969
      • Citation of InvivoChem ARRY-470 by Cell 2020, PMID: 33142117 PMCID: PMC8100789
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem 5-azacytidine (V0404) by Nature 2021, PMID: 34433969
      • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
      • Citation of InvivoChem Eprenetapopt (APR-246) by Science Adv 2022: 8, eabm9427.
      • Citation of InvivoChem BMH-21 (V1435) by Cell Stem Cell 2020, 26(6): 845-861.e12.
      • Citation of InvivoChem BMS-582949 (V2668) by Cells 2020, 9(6):1472.
      • Citation of InvivoChem Resveratrol (V0430) by Arterioscler Thromb Vasc Biol 2020, 40(10):2408
      • Citation of InvivoChem LGK974 /WNT974 (V1353) by Cancer Cell 2021 Apr 12;39(4):529-547.e7.
      • Citation of InvivoChem V1386 Napabucasin (BBI-608) by J Exp Clin Cancer Res 2021 Oct 13;40(1):319.
      • Citation of InvivoChem S63845 (V2797) by Cell Death and Disease 2020, 11:316.
      • Citation of InvivoChem LGK974 /WNT974 (V1353) by Cancer Cell 2021 Apr 12;39(4):529-547.e7.
      • Citation of InvivoChem Apiin (V4467) by J Med Chem 2020, 63(15):8338-8358.
      • Citation of InvivoChem V0001 venetoclax by WO2021231323A1

      2023产品目录2023-2024产品目录

      2023产品目录

      2023产品目录产品使用说明书(通用型)

      顾客使用 InvivoChem产品发表科研文献
      • 产品理化性质和储存条件
      • 实验参考方法
      • 质控文件
      • 生物活性
      • 顾客评价
      Molecular Weight (MW)806.94
      FormulaC42H56F2N8O6
      CAS No.1260251-31-7
      Storage-20℃ for 3 years in powder form
      -80℃ for 2 years in solvent
      Solubility (In vitro)DMSO: 100 mg/mL (123.9 mM)
      Water:<1 mg/mL (slightly soluble or insoluble)
      Ethanol: 55 mg/mL (68.1 mM)
      Solubility (In vivo)15% Captisol: 15mg/mL
      SynonymTL32711; TL-32711; TL 32711; SMAC mimetic; Birinapant
      Chemical Name(2S,2'S)-N,N'-((2S,2'S)-((3S,3'S,5R,5'R)-5,5'-((6,6'-difluoro-1H,1'H-[2,2'-biindole]-3,3'-diyl)bis(methylene))bis(3-hydroxypyrrolidine-5,1-diyl))bis(1-oxobutane-2,1-diyl))bis(2-(methylamino)propanamide)
      • 摩尔计算器
      • 稀释计算器
      • The molarity calculator equation

        Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

        • Mass
        • Concentration
        • Volume
        • Molecular Weight *
        • =
        • ×
        • ×
      • The dilution calculator equation

        Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

        This equation is commonly abbreviated as: C1V1 = C2V2

        • Concentration (start)
        • ×
        • Volume (start)
        • =
        • Concentration (final)
        • ×
        • Volume (final)
        • ×
        • =
        • ×
        • C1
        •  
        • V1
        •  
        • C2
        •  
        • V2
      In VitroBirinapant binds with XIAP and cIAP1 with Kd of 45 and<1 nM, respectively. Birinapant induces cell death as a single agent in TRAIL-insensitive SUM190 (ErbB2-overexpressing) cells (IC50, ~300 nM), and significantly increases potency of TRAIL-induced apoptosis in TRAIL-sensitive SUM149 (triple-negative, EGFR-activated) cells. Birinapant causes rapid cIAP1 degradation, caspase activation, PARP cleavage, and NF-κB activation. Birinapant in combination with TNF-α(1 ng/mL) inhibits the growth of human melanoma cell lines WTH202, WM793B, WM1366 and WM164 with IC50s of 1.8, 2.5, 7.9 and 9 nM, respectively.
      In VivoBirinapant (30 mg/kg) treatment significantly induces abrogation of tumor growth in melanoma xenotransplantation models 451Lu with.
      Animal modelHuman melanoma xenografts 451Lu
      Formulation & Dosage12.5% Captisol in distilled water; 30 mg/kg; i.p. 3 times per week 
      References[1] Krepler C, et al. Clin Cancer Res, 2013, 19(7), 1784-1794.

      These protocols are for reference only. InvivoChem does not independently validate these methods.

       

      Birinapant

      		 

      Birinapant

      Krepler C, et al. Clin Cancer Res, 2013, 19(7), 1784-1794.
      		 

      Birinapant

      Krepler C, et al. Clin Cancer Res, 2013, 19(7), 1784-1794.

      评论

        Home Prev Next Last page / pices

        发评论

        ×
        你的资料在我们这儿很安全* 必填项。
        InvivoChem的所有产品仅用于作科学研究，不面向患者销售
        联系我们
        联系我们
        电话：020-31522723
        QQ：463611831
        电子邮箱: sales@invivochem.net
        获得最新产品资讯、折扣和优惠
        • 姓名*
        • *
        • 邮箱*
        • *
        • 详细说明：
        • *
        Copyright 2020 InvivoChem LLC | All Rights Reserved
        粤ICP备20063088号
          网站地图